Henning Tim Langer

8PUBLICATIONS
6CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)Biological adaptationMolecular targetsMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 06, 2025
Pharmacological weight loss with incretin-based therapies does not result in a disproportionate loss of muscle mass or function in obese mice and humans.

Henning Tim Langer, Natalie K Gilmore, Chris M T Hayden

|May 23, 2024
Restoring adiponectin via rosiglitazone ameliorates tissue wasting in mice with lung cancer.

Henning Tim Langer, Shakti Ramsamooj, Ezequiel Dantas

|May 17, 2024
AMPK as a mediator of tissue preservation: time for a shift in dogma?

Henning Tim Langer, Maria Rohm, Marcus DaSilva Goncalves

|Aug 17, 2022
Dominant-negative p53-overexpression in skeletal muscle induces cell death and fiber atrophy in rats.

Henning T Langer, Agata A Mossakowski, Rasheed Sule

|Nov 11, 2021
Cannabidiol Does Not Impact Acute Anabolic or Inflammatory Signaling in Skeletal Muscle <i>In Vitro</i>.

Henning T Langer, Alec Avey, Keith Baar

|Aug 19, 2021
A mutation in desmin makes skeletal muscle less vulnerable to acute muscle damage after eccentric loading in rats.

Henning T Langer, Agata A Mossakowski, Alec M Avey

Pageof 2

Frequent Collaborators

1 joint publications

Lucas R Smith

1 joint publications

Rasheed Sule

1 joint publications

Aldrin Gomes

1 joint publications

Stefan Kempa